PURE Bioscience, Inc.

PURE · OTC
Analyze with AI
7/31/2025
7/31/2024
7/31/2023
7/31/2022
Assets
Cash & Equivalents$334,000$349$1,095$3,391
Short-Term Investments$0$0$0$0
Receivables$474,000$298$285$201
Inventory$141,000$56$88$179
Other Curr. Assets$98,000$102$136$93
Total Curr. Assets$1,047,000$805$1,604$3,864
Property Plant & Equip (Net)$11,000$13$221$620
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0-$221-$620
Total NC Assets$11,000$13$221$620
Other Assets$0$0$0$0
Total Assets$1,058,000$818$1,825$4,484
Liabilities
Payables$784,000$601$422$488
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$154,000$132$110$87
Total Curr. Liab.$938,000$733$532$575
LT Debt$5,236,000$2,949$1,021$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$5,236,000$2,949$1,021$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$6,174,000$3,682$1,553$575
Equity
Pref Stock$0$0$0$0
Common Stock$1,119,000$1,119$1,119$1,114
Retained Earnings-$138,994,000-$136,595-$133,245-$129,284
AOCI$0$0$0-$0
Other Equity$132,759,000$132,612$132,398$132,079
Total Equity-$5,116,000-$2,864$272$3,909
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,058,000$818$1,825$4,484
Net Debt$4,902,000$2,600-$74-$3,391
PURE Bioscience, Inc. (PURE) Financial Statements & Key Stats | AlphaPilot